432 related articles for article (PubMed ID: 26595522)
1. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
Chen JY; Chen YJ; Yen CJ; Chen WS; Huang WC
Oncotarget; 2016 Jan; 7(1):473-89. PubMed ID: 26595522
[TBL] [Abstract][Full Text] [Related]
2. miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin.
Chen WS; Yen CJ; Chen YJ; Chen JY; Wang LY; Chiu SJ; Shih WL; Ho CY; Wei TT; Pan HL; Chien PH; Hung MC; Chen CC; Huang WC
Oncotarget; 2015 Sep; 6(28):25962-74. PubMed ID: 26296971
[TBL] [Abstract][Full Text] [Related]
3. The
Chen JY; Huang WC; Wei CT; Chien PH; Chen YJ
Anticancer Res; 2019 Feb; 39(2):721-726. PubMed ID: 30711950
[TBL] [Abstract][Full Text] [Related]
4. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells.
Cao K; Gong H; Qiu Z; Wen Q; Zhang B; Tang T; Zhou X; Cao T; Wang B; Shi H; Wang R
Tumour Biol; 2016 Aug; 37(8):10375-82. PubMed ID: 26846102
[TBL] [Abstract][Full Text] [Related]
6. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
[TBL] [Abstract][Full Text] [Related]
8. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
[TBL] [Abstract][Full Text] [Related]
9. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
10. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
12. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
13. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
14. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
[TBL] [Abstract][Full Text] [Related]
16. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
17. Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Zhang Y; Wu SS; Chen XH; Tang ZH; Yu YS; Zang GQ
Med Sci Monit; 2017 Nov; 23():5202-5210. PubMed ID: 29089476
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
Liu L; Li Y; Zhang S; Yu D; Zhu M
Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
20. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
